Human Gene Therapy is categorized under Rehabilitation Center, Outpatient Treatment in Philadelphia, PA and active since 2012.
Human Gene Therapy was established in 2012, and today employs 1 to 4, earning Unknown per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 621498 by the NAICS.
If you are seeking more information, feel free to contact Angela Adams at the company’s single location by writing to 125 South 31st St # 2000, Philadelphia, Pennsylvania PA 19104 or by phoning (215) 746-8936. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Human Gene Therapy |
| Contact Person: | Angela Adams |
| Address: | 125 South 31st St # 2000, Philadelphia, Pennsylvania 19104 |
| Phone Number: | (215) 746-8936 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Rehabilitation Center, Outpatient Treatment |
| SIC Code: | 8093 |
| NAICS Code: | 621498 |
| Share This Business: |
Human Gene Therapy was started in 2012 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 621498. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Angela Adams for inquiries that concern Human Gene Therapy by calling the company number (215) 746-8936, as your correspondence is most welcome. Additionally, the physical location of the single location of Human Gene Therapy can be found at the coordinates 39.95275,-75.185258 as well as the street address 125 South 31st St # 2000 in Philadelphia, Pennsylvania 19104.
For its online presence, you may visit Human Gene Therapy’s website at and engage with its social media outlets through on Twitter and on Facebook.